In that study, Imai et al. evaluated the immunoexpression of KIF11 in CRC tissues taking into account percentage score and, based on this, KIF11-positivity was reported to be more than twice as high compared to percentage positivity obtained by us (62% vs. 27%). The gene discussed is KIF11; the disease is colorectal carcinoma.